Norbrook Laboratories Ltd has expanded its popular Loxicom range with an additional two products – a chewable tablet for dogs and 5ml presentation of Loxicom Oral Suspension for cats.
Leading veterinary pharmaceuticals manufacturer, Norbrook Laboratories Ltd has expanded its popular Loxicom range with an additional two products.
Loxicom is Norbrook’s meloxicam range, which is one of the most commonly used small animal NSAIDs across the UK and Europe. It is highly trusted in practices due to its proven record of efficacy.
New to the Loxicom for Dogs range is a chewable tablet available with 1mg and 2.5mg meloxicam per tablet, while the Loxicom for Cats range will see a 5ml presentation of Loxicom Oral Suspension added to the existing 15ml option.
Michelle Jones, Norbrook brand manager (Small Animals), said: “Loxicom chewable tablets, which are flavoured with pork, are a highly palatable option to prescribing meloxicam to dogs and as they can be used for long term and short term treatment, they are available in packs of either 100 or 20.
“Loxicom Oral Suspension for Cats, which we launched two years ago, has now become the brand of choice for many vets. We introduced clear bottles to enable easy monitoring of usage and tight-fitting syringes to allow for accurate, mess-free administration which were very well received by our customers.
“The new 5ml presentation, which will be offered in the same way, will allow vets to dispense smaller quantities of the product as required without any unnecessary wastage.”
- The new Loxicom products are now available to order in the UK and Ireland with some exciting launch offers. Speak to your local Norbrook rep for details.